Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal

Background: Using adequate infection control measures, the rate of vertical transmission of human immunodeficiency virus (HIV) during pregnancy, has been reduced to 3% in Chile. Aim: To determine vertical transmission rate and risk factors associated to perinatal infection in pregnant women with kno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ovalle S,Alfredo, Vizueta R,Eloísa, Casals C,Alejandro, Northland A,Rebeca, González R,Reinaldo, Labbé M,Eduardo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2003
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000600007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872003000600007
record_format dspace
spelling oai:scielo:S0034-988720030006000072004-12-13Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatalOvalle S,AlfredoVizueta R,EloísaCasals C,AlejandroNorthland A,RebecaGonzález R,ReinaldoLabbé M,Eduardo HIV infections HIV seropositivity Perinatal care Pregnancy complications infections Background: Using adequate infection control measures, the rate of vertical transmission of human immunodeficiency virus (HIV) during pregnancy, has been reduced to 3% in Chile. Aim: To determine vertical transmission rate and risk factors associated to perinatal infection in pregnant women with known (KI) and unknown HIV infection (UI). Patients and methods: HIV infected pregnant women whose deliveries were attended at the San Borja Arriaran Hospital were included. Antiretroviral therapy (ART) has been used since 1995 (Zidovudine 13 patients, bitherapy 4 and triple therapy 14 patients). Newborns have received ART since 1995. Premature labor without evident cause, premature rupture of membranes, and rupture of membranes over 4 h before delivery were evaluated. Delivery was by elective cesarean section since 1993. Breast feeding was avoided. Pregnant women with UI (suspected disease after delivery due to child or mother pathology) did not received ART. Delivery and breast feeding were managed with common obstetrical-neonatal criteria. Results: Fifty three HIV infected pregnant women were studied (43 with KI and 10 with UI). Four children (36.4%) from the KI group and seven (63.6%) from the UI group became infected. The global rate of vertical transmission among KI group was significantly lower than UI group: 9.5% (4/42) vs 70.0% (7/10) p <0.001. Using ART, this rate was further reduced to 6.5% (2/31) and with bitherapy or triple therapy to 0% (0/18). Breast feeding, vaginal delivery, premature delivery with no clinical cause, premature rupture of membranes, rupture of membranes longer than 4 h and lack of ART, were significantly more common in the UI group, compared with KI group. Conclusions: Vertical transmission in pregnant women with KI is significantly lower compared with UI. Risk factors increasing HIV perinatal infection are: breast feeding, lack of ART, vaginal delivery, premature rupture of membranes, rupture of membranes >4 h and premature labor without a clinical cause (Rev Méd Chile 2003; 131: 633-640)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.131 n.6 20032003-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000600007es10.4067/S0034-98872003000600007
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic HIV infections
HIV seropositivity
Perinatal care
Pregnancy complications
infections
spellingShingle HIV infections
HIV seropositivity
Perinatal care
Pregnancy complications
infections
Ovalle S,Alfredo
Vizueta R,Eloísa
Casals C,Alejandro
Northland A,Rebeca
González R,Reinaldo
Labbé M,Eduardo
Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
description Background: Using adequate infection control measures, the rate of vertical transmission of human immunodeficiency virus (HIV) during pregnancy, has been reduced to 3% in Chile. Aim: To determine vertical transmission rate and risk factors associated to perinatal infection in pregnant women with known (KI) and unknown HIV infection (UI). Patients and methods: HIV infected pregnant women whose deliveries were attended at the San Borja Arriaran Hospital were included. Antiretroviral therapy (ART) has been used since 1995 (Zidovudine 13 patients, bitherapy 4 and triple therapy 14 patients). Newborns have received ART since 1995. Premature labor without evident cause, premature rupture of membranes, and rupture of membranes over 4 h before delivery were evaluated. Delivery was by elective cesarean section since 1993. Breast feeding was avoided. Pregnant women with UI (suspected disease after delivery due to child or mother pathology) did not received ART. Delivery and breast feeding were managed with common obstetrical-neonatal criteria. Results: Fifty three HIV infected pregnant women were studied (43 with KI and 10 with UI). Four children (36.4%) from the KI group and seven (63.6%) from the UI group became infected. The global rate of vertical transmission among KI group was significantly lower than UI group: 9.5% (4/42) vs 70.0% (7/10) p <0.001. Using ART, this rate was further reduced to 6.5% (2/31) and with bitherapy or triple therapy to 0% (0/18). Breast feeding, vaginal delivery, premature delivery with no clinical cause, premature rupture of membranes, rupture of membranes longer than 4 h and lack of ART, were significantly more common in the UI group, compared with KI group. Conclusions: Vertical transmission in pregnant women with KI is significantly lower compared with UI. Risk factors increasing HIV perinatal infection are: breast feeding, lack of ART, vaginal delivery, premature rupture of membranes, rupture of membranes >4 h and premature labor without a clinical cause (Rev Méd Chile 2003; 131: 633-640)
author Ovalle S,Alfredo
Vizueta R,Eloísa
Casals C,Alejandro
Northland A,Rebeca
González R,Reinaldo
Labbé M,Eduardo
author_facet Ovalle S,Alfredo
Vizueta R,Eloísa
Casals C,Alejandro
Northland A,Rebeca
González R,Reinaldo
Labbé M,Eduardo
author_sort Ovalle S,Alfredo
title Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
title_short Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
title_full Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
title_fullStr Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
title_full_unstemmed Infección por virus de inmunodeficiencia humana en la embarazada: Importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
title_sort infección por virus de inmunodeficiencia humana en la embarazada: importancia del conocimiento de la infección en el embarazo y factores de riesgo en la transmisión perinatal
publisher Sociedad Médica de Santiago
publishDate 2003
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000600007
work_keys_str_mv AT ovallesalfredo infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
AT vizuetareloisa infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
AT casalscalejandro infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
AT northlandarebeca infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
AT gonzalezrreinaldo infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
AT labbemeduardo infeccionporvirusdeinmunodeficienciahumanaenlaembarazadaimportanciadelconocimientodelainfeccionenelembarazoyfactoresderiesgoenlatransmisionperinatal
_version_ 1718436096828768256